|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 22702492.4 (espacenet) (Federated) (European Patent Register), 20220209 | | Patent/reg. no. and date | DK/EP 4228598, 20231227 | | Publication date | 20230823 | | Priority no. and date | EP 21172232, 20210505 | | EP pub. no. and date |
EP 4228598 20230823 | | Effective date | | | Applicant/owner | Sodha Pharma Consulting GmbH, Finkenstrasse 11
4104 Oberwil, CH | | Applicant ref. no. | | | Inventor | RAVINDRAKUMAR JIVAN, Sodha,
4104 Oberwil, CH | | Representative | | | Opponent | | | IPC Class | A61K 31/436 (2006.01) , A61K 47/10 (2017.01) , A61K 9/06 (2006.01) , A61K 9/14 (2006.01) , A61P 17/00 (2006.01) , A61P 35/00 (2006.01) | | Title | TOPICAL FORMULATION COMPRISING SIROLIMUS | | Int. application no. | EP2022053113 | | Int. publication no. | WO2022233468 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
